Home›People›James Christensen
James Christensen

James Christensen

President and Chief Executive Officer, director at Terremoto Biosciences.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 22, 2026·Suggest an edit

About James Christensen

James Christensen is a president and chief executive officer, director at Terremoto Biosciences.

Experience

This experience comes from James Christensen's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Christensen in the role, so the role may have started earlier or lasted longer.

Terremoto Biosciences, Inc. Current
President and Chief Executive Officer, director
CEO and President (2025 – Present)
2025 – Present · South San Francisco, CA
Develops targeted medicines for patients with cancer and genetic diseases.
OrbiMed Current
Venture Partner
2024 – Present
Boundless Bio Current
Member Board of Directors
2023 – Present
Bristol Myers Squibb
CSO and EVP Research, Mirati Therapeutics, a Bristol Myers Squibb Company
2024 – 2025
Mirati Therapeutics
CSO and Executive Vice President Research
2013 – 2025
Pfizer
Sr, Director
2003 – 2013
Warner Lambert/Agouron/Pfizer
Sr Director, Oncology Precision Medicine
1998 – 2013
TORCH collaboration
Sr Director, Pfizer
2003 – 2011
Pharmacia Corporation
Team Leader
2000 – 2003
SUGEN
Group leader
1999 – 2003

Key Colleagues at Startups

The people James Christensen works with at each company, as listed on that company's latest Form D.

Terremoto Biosciences, Inc. · Form D, Apr 22, 2026
MG
GL
Grace Lu
Executive officer
Reid Huber
Reid Huber
Partner, Third Rock Ventures and director
Peter Thompson
Peter Thompson
Co-founder and Director, Terremoto
Charles Baum
Charles Baum
Executive Chairman

Sources

  1. SECTerremoto Biosciences, Inc. Form D, filed Apr 22, 2026